23Mar/14

FDA approves Celgene's Otezla for psioratic arthritis – PharmaTimes


Headlines & Global News

FDA approves Celgene’s Otezla for psioratic arthritis
PharmaTimes
Treatment for PSA, which affects about 30% of the 125 million people worldwide who have psoriasis, currently involves corticosteroids, disease-modifying antirheumatic drugs (DMARDs) and injectable tumour necrosis factor (TNF) inhibitors, notably AbbVie
Celgene’s Otezla is first oral therapy OKed by FDA for adults with active The Pharma Letter
FDA Approves Otezla, New Medication For Psoriatic ArthritisThe Almagest
FDA approves Celgene drug for psoriatic arthritisYahoo News
Reuters
all 54 news articles »
22Mar/14

David White: Carrs get competitive, maybe all the way to an NFL camp – Fresno Bee


Fresno Bee

David White: Carrs get competitive, maybe all the way to an NFL camp
Fresno Bee
Just like that, there wasn’t enough hydrocortisone in the greater Bakersfield area to soothe David’s itch to get un-disappeared from the NFL. “I never fully closed that door, but I was fine with it,” David said. “Then Derek came over and wanted to

and more »

22Mar/14

FDA approves Celgene drug for psoriatic arthritis – Yahoo News


Guardian Liberty Voice

FDA approves Celgene drug for psoriatic arthritis
Yahoo News
Current treatments for the condition include corticosteroids and a class of injected biotech medicines known as tumor necrosis factor (TNF) blockers, such as AbbVie Inc’s big selling Humira and Remicade from Johnson & Johnson. The TNF blockers are
UPDATE 2-US FDA approves Celgene drug for psoriatic arthritisReuters
Psoriatic Arthritis Medication Otezla Approved by FDAGuardian Liberty Voice
FDA approves apremilast to treat adults with psoriatic arthritisHealio
Xinhua
all 47 news articles »